Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 798

1.

The program cost and cost-effectiveness of screening men for Chlamydia to prevent pelvic inflammatory disease in women.

Gift TL, Gaydos CA, Kent CK, Marrazzo JM, Rietmeijer CA, Schillinger JA, Dunne EF.

Sex Transm Dis. 2008 Nov;35(11 Suppl):S66-75. doi: 10.1097/OLQ.0b013e31818b64ac.

PMID:
18830137
2.
3.

Epidemiological, social, diagnostic and economic evaluation of population screening for genital chlamydial infection.

Low N, McCarthy A, Macleod J, Salisbury C, Campbell R, Roberts TE, Horner P, Skidmore S, Sterne JA, Sanford E, Ibrahim F, Holloway A, Patel R, Barton PM, Robinson SM, Mills N, Graham A, Herring A, Caul EO, Davey Smith G, Hobbs FD, Ross JD, Egger M; Chlamydia Screening Studies Project Group.

Health Technol Assess. 2007 Mar;11(8):iii-iv, ix-xii, 1-165. Review.

4.

Screening for Chlamydia trachomatis in women 15 to 29 years of age: a cost-effectiveness analysis.

Hu D, Hook EW 3rd, Goldie SJ.

Ann Intern Med. 2004 Oct 5;141(7):501-13. Erratum in: Ann Intern Med. 2004 Nov 2;141(9):744.

PMID:
15466767
5.

Cost-effectiveness of partner pharmacotherapy in screening women for asymptomatic infection with Chlamydia Trachomatis.

Postma MJ, Welte R, van den Hoek JA, van Doornum GJ, Jager HC, Coutinho RA.

Value Health. 2001 May-Jun;4(3):266-75.

PMID:
11705188
6.

Cost-effectiveness of screening swab or urine specimens for Chlamydia trachomatis from young Canadian women in Ontario.

Goeree R, Jang D, Blackhouse G, Chong S, Mahony J, Sellors J, Foy A, Chernesky M.

Sex Transm Dis. 2001 Dec;28(12):701-9.

PMID:
11725225
7.

Partner notification to prevent pelvic inflammatory disease in women. Cost-effectiveness of two strategies.

Howell MR, Kassler WJ, Haddix A.

Sex Transm Dis. 1997 May;24(5):287-92.

PMID:
9153739
8.
9.

Effectiveness of chlamydia screening: systematic review.

Low N, Bender N, Nartey L, Shang A, Stephenson JM.

Int J Epidemiol. 2009 Apr;38(2):435-48. doi: 10.1093/ije/dyn222. Epub 2008 Dec 5. Review.

PMID:
19060033
10.

The Philadelphia High-School STD Screening Program: key insights from dynamic transmission modeling.

Fisman DN, Spain CV, Salmon ME, Goldberg M.

Sex Transm Dis. 2008 Nov;35(11 Suppl):S61-5. doi: 10.1097/OLQ.0b013e3181802822.

PMID:
18607306
11.

Overestimation of complication rates in evaluations of Chlamydia trachomatis screening programmes--implications for cost-effectiveness analyses.

van Valkengoed IG, Morré SA, van den Brule AJ, Meijer CJ, Bouter LM, Boeke AJ.

Int J Epidemiol. 2004 Apr;33(2):416-25. Review.

PMID:
15082651
12.

Screening women for chlamydia trachomatis in family planning clinics: the cost-effectiveness of DNA amplification assays.

Howell MR, Quinn TC, Brathwaite W, Gaydos CA.

Sex Transm Dis. 1998 Feb;25(2):108-17.

PMID:
9518379
13.

Cost effectiveness analysis of a population based screening programme for asymptomatic Chlamydia trachomatis infections in women by means of home obtained urine specimens.

van Valkengoed IG, Postma MJ, Morré SA, van den Brule AJ, Meijer CJ, Bouter LM, Boeke AJ.

Sex Transm Infect. 2001 Aug;77(4):276-82.

14.

A cost-effectiveness evaluation of a jail-based chlamydia screening program for men and its impact on their partners in the community.

Gift TL, Lincoln T, Tuthill R, Whelan M, Briggs LP, Conklin T, Irwin KL.

Sex Transm Dis. 2006 Oct;33(10 Suppl):S103-10.

PMID:
17003677
15.

Developments in the screening for Chlamydia trachomatis: a review.

Kohl KS, Markowitz LE, Koumans EH.

Obstet Gynecol Clin North Am. 2003 Dec;30(4):637-58. Review.

PMID:
14719842
16.

Cost-effectiveness of screening programs for Chlamydia trachomatis: a population-based dynamic approach.

Welte R, Kretzschmar M, Leidl R, van den Hoek A, Jager JC, Postma MJ.

Sex Transm Dis. 2000 Oct;27(9):518-29.

PMID:
11034526
17.

Cost-effectiveness analysis of screening adolescent males for Chlamydia on admission to detention.

Blake DR, Gaydos CA, Quinn TC.

Sex Transm Dis. 2004 Feb;31(2):85-95.

PMID:
14743071
18.

The cost and cost-effectiveness of opportunistic screening for Chlamydia trachomatis in Ireland.

Gillespie P, O'Neill C, Adams E, Turner K, O'Donovan D, Brugha R, Vaughan D, O'Connell E, Cormican M, Balfe M, Coleman C, Fitzgerald M, Fleming C.

Sex Transm Infect. 2012 Apr;88(3):222-8. doi: 10.1136/sextrans-2011-050067. Epub 2012 Jan 2.

PMID:
22213681
19.

An economic evaluation of a school-based sexually transmitted disease screening program.

Wang LY, Burstein GR, Cohen DA.

Sex Transm Dis. 2002 Dec;29(12):737-45.

PMID:
12466713

Supplemental Content

Support Center